PT Haloni Jane Tbk is proud to announce its outstanding HALO Q2 2025 Performance
Jakarta, July 1, 2025 – PT Haloni Jane Tbk (HALO), a medical glove manufacturer listed on the stock exchange, proudly announces outstanding financial performance for the Second Quarter of 2025 (period ended June 30, 2025). The released financial report underscores very robust business fundamentals driven by a successful global market penetration strategy.
Export Sales Explode, Driving Significant Revenue Growth
The Company successfully recorded total sales of Rp 100.45 billion, surging by 47.41% Year-on-Year (YoY) compared to Rp 68.14 billion in the same period last year.
This stellar achievement was dominated by the export segment, which skyrocketed by over 218%, fueled by successful entry into strategic markets, particularly in the Latin American region. This drastic increase proves the global competitiveness of HALO’s products and validates its effective expansion strategy.
Financial Health at Peak Levels: Cash Reserves Jump 1,339% – HALO Q2 2025 Performance
The strength of the HALO Q2 2025 Performance is clearly reflected in its cash position, providing an unshakeable liquidity foundation for future expansion plans. HALO’s financial health is in excellent shape.
- Cash Reserves Surge: The Company’s cash and cash equivalents position dramatically soared by 1,339% to Rp 12.63 billion as of June 2025, from Rp 877.52 million at the end of December 2024. This massive increase demonstrates the Company’s ability to generate strong cash flow and will be the main pillar for strategic investments without relying on external financing.
- Very Strong Liquidity: The Company’s current ratio stands at 2.84, affirming HALO’s strong ability to meet all its short-term obligations with available current assets.
Stock Outlook: Price Stability as Untapped Value Potential
While the Company’s fundamentals show extraordinary strength, HALO’s stock price movement has remained stable, hovering around the Rp 80 level in recent months.
Management views this condition as untapped value potential. We believe that our strong fundamentals, supported by explosive export growth and abundant cash reserves, will drive the share price toward its intrinsic value in the future.
With solid fundamentals, sustained export growth, and a very strong cash position, HALO is well-positioned to continue its positive growth trajectory and optimize returns for all shareholders.
For more information, please contact:
PT Haloni Jane Tbk
Email: info@halonijane.co.id
Phone: +62 21 3000 8777
Whatsapp: +62 812 6886 8062
Website: www.halonijane.co.id
About PT Haloni Jane Tbk
PT Haloni Jane Tbk is part of the Shamrock Group, which has over 35 years of experience as a trusted medical glove manufacturer. PT Haloni Jane Tbk itself has been operating for over 25 years, focusing on consistently producing high-quality disposable latex and nitrile gloves for examination, surgical, and industrial needs.
Our products are used in over 50 countries, both under our own brand and private label, with international certifications such as FDA, CE/MDR, and ISO, guaranteeing the best standards for quality and safety.
We manage the factory holistically from upstream to downstream, utilizing biodegradable natural rubber raw materials sourced directly from the company’s rubber plantations, which are managed with sustainability principles. This commitment not only maintains product quality but also supports responsible environmental conservation.
EN 
ID